AGILENT TECHNOLOGIES, INC. (A) Profit Breakdown
- 2026-07-31: Products $774.00M; Service, Other $268.00M.
- 2025-07-31: Products $653.00M; Service, Other $235.00M.
Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.
- Available history
- 2007-10-31 to 2026-07-31
- Data captured
Profit by product
Gross margin: each quarter (3 month)
| Quarter end | Products | Service, Other |
|---|---|---|
| 2026-07-31 | $774.00M derived | $268.00M derived |
| 2025-07-31 | $653.00M derived | $235.00M derived |
Operating income: each quarter (3 month)
| Quarter end | Agilent CrossLab | Life Sciences and Diagnostics Markets | Applied Markets |
|---|---|---|---|
| 2026-07-31 | $270.00M | $176.00M | $86.00M |
| 2025-07-31 | $248.00M | $118.00M | $71.00M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |